Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The requested study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T17:32:37.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T17:10:47.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the 403 error page otherwise remains the same.
    Difference
    0.2%
    Check dated 2026-10-10T18:07:35.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the site chrome (header/footer), replacing the previously visible study details and related content with an access-denied screen.
    Difference
    18%
    Check dated 2026-09-19T19:29:18.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Melanoma and the related topics section (MedlinePlus Genetics) have been removed from the page, reducing disease-specific context and access to related resources.
    Difference
    0.2%
    Check dated 2026-09-12T17:39:50.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Melanoma and MedlinePlus Genetics as related topics and updated the page revision from v3.6.5 to v3.6.6.
    Difference
    0.2%
    Check dated 2026-08-29T21:00:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.